DR. RAFFERTY & PARTNERS
BALLYCLARE GROUP PRACTICE, BALLYCLARE GROUP PRACTICE, BALLYCLARE HEALTH CENTRE, GEORGE AVENUE, BALLYCLAREStroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 130 | 140 | 92.9% | |
STROKE 9 | 2006 | 159 | 167 | 95.2% | |
Stroke 12 | 2007 | 163 | 173 | 94.2% | |
Stroke 12 | 2008 | 170 | 183 | 92.9% | |
Stroke 12 | 2009 | 166 | 183 | 90.7% | |
Stroke 12 | 2010 | 165 | 182 | 90.7% | |
STROKE 12 | 2011 | 170 | 184 | 92.4% | |
STROKE 12 | 2012 | 176 | 188 | 93.6% | |
STROKE 12 | 2013 | 171 | 179 | 95.5% | |
STIA007NI | 2014 | 164 | 171 | 95.9% | |
STIA007 | 2015 | 161 | 170 | 94.7% | |
STIA007 | 2016 | 156 | 163 | 95.7% | |
STIA007 | 2017 | 150 | 160 | 93.8% | |
STIA007 | 2018 | 146 | 158 | 92.4% | |
STIA007 | 2019 | 142 | 155 | 91.6% | |
STIA007 | 2020 | 146 | 161 | 90.7% | |
STIA007 | 2021 | 143 | 159 | 89.9% |